Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Hepatitis C × Raltegravir Potassium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Failure 1 Hepatitis C 1 Hepatitis B 1 Hepatic Insufficiency 1 HIV Infections 1 Carcinoma, Hepatocellular 1

Interventions

elbasvir-grazoprevir drug combination 1 Raltegravir Potassium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01022476 2013-07-18

LIVERAL

ANRS, Emerging Infectious Diseases

Phase 1/2 Completed

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, HIV Infections, Liver Failure, Hepatic Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡